Tech hype

Should Christians resist or lean into AI?

As is probably obvious from previous episodes, John is extremely interested in generative AI and thinks it will be the next transformative technology to entirely up-end how society works. Tim, however, is much more sceptical and thinks a lot of the rhetoric around AI is overblown. So, prompted by Tim sharing an AI-sceptical blog, in this episode we talk through the anatomy of a tech hype bubble, looking at previous cases such as the internet, cryptocurrency and smartphones to figure out where AI might be on the ‘S-curve’ of tech adoption. How can Christians live responsibly and faithfully through these moments, where culture is running away with itself about something new and flashy? Is it incumbent on us not to get left behind and languish in ignorance about something which could change the world? Or should we be consciously opting out of the techno-optimist hype and preferring prudent caution over giddy excitement?

The Ed Zitron blog on AI scepticism
Marc Andreessen’s Techno-Optimist Manifesto

Listen to other episodes of Matters of Life and Death or find us on Spotify, Apple Podcasts, Pocket Casts, Google Podcasts, Podcast Addict, Castbox or whatever app you use to subscribe and receive new episodes sent straight to your device.

Tags
Most read posts
What can we learn from how the early church lived out their faith during their own pandemics?
Navigating the transitions of later life
How are young people different to those who came before, and what can we learn from them?
Living faithfully as we approach retirement, dependence, dementia and death
Investing in the next generation - Lessons from John Stott and others
Recent posts
There may be no straightforward way to turn around a struggling health service
Assisted suicide: Euthanasia tourism takes off in the US amid fresh push to change law in Britain
Innocence and guilt, partial evidence, and living with unknowns
Capacities, calling, relationships - disentangling this foundational theological tenet
The long and sad history of medical trial scandals gains another sobering chapter